Best Penny Stocks Under 5 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.05 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.05. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Cutera NASDAQ:CUTR$0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. More about CuteraMarket Capitalization$787 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+7,592.3% Upside)Volume27.70 million sharesAverage Volume2.20 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Cannabist OTCMKTS:CBSTF$0.04 0.00 (-1.98%) As of 03/21/2025 03:59 PM EasternThe Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. More about CannabistConsensus RatingHoldVolume375,779 sharesAverage Volume945,037 sharesToday's Range$0.04▼$0.0550-Day Range$0.04▼$0.0752-Week Range$0.04▼$0.443. Viracta Therapeutics NASDAQ:VIRX$0.02 0.00 (-8.40%) As of 03/21/2025 03:54 PM EasternViracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$910 thousandP/E Ratio-0.02Consensus RatingModerate BuyConsensus Price Target$4.05 (+17,585.6% Upside)Volume105,668 sharesAverage Volume1.08 million shares4. BIOLASE NASDAQ:BIOL$0.0076 +0.00 (+7.04%) As of 03/21/2025BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. More about BIOLASEMarket Capitalization$254 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$1.20 (+15,689.5% Upside)Volume46,192 sharesAverage Volume2.58 million shares5. Nextech3D.AI OTCMKTS:NEXCF$0.03 +0.00 (+1.81%) As of 03/21/2025 03:55 PM EasternNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. More about Nextech3D.AIMarket Capitalization$4.05 millionP/E Ratio-0.71Consensus RatingBuyConsensus Price Target$0.25 (+786.5% Upside)Volume258,273 sharesAverage Volume415,675 shares6. Loop Media NYSEAMERICAN:LPTV$0.04 +0.00 (+7.64%) As of 03/21/2025 03:12 PM EasternLoop Media, Inc operates as a multichannel digital video platform media company in the United States. The company offers hand-curated music video content licensed from major and independent record labels, including Universal Music Group, Sony Music Entertainment, and Warner Music Group; and non-music video content, which is licensed or acquired from third parties, such as action sports clips, drone and atmospheric footage, trivia, news headlines, lifestyle channels, and kid-friendly videos, as well as movie, television and video game trailers, and other content. More about Loop MediaMarket Capitalization$3.63 millionP/E Ratio-0.15Consensus RatingBuyConsensus Price Target$0.50 (+1,044.2% Upside)Volume139,706 sharesAverage Volume124,908 sharesRemove Ads7. MetaWorks Platforms OTCMKTS:MWRK$0.01 +0.00 (+64.90%) As of 03/21/2025MetaWorks Platforms, Inc provides blockchain and Web3 development platform. It offers turnkey set of services for companies to develop and integrate blockchain and cryptocurrency technologies into their business operations. More about MetaWorks PlatformsMarket Capitalization$1.17 millionP/E Ratio-0.16Consensus RatingHoldVolume134,784 sharesAverage Volume226,363 sharesToday's Range$0.0076▼$0.01508. DZS NASDAQ:DZSI$0.0026 -0.01 (-73.74%) As of 03/21/2025DZS Inc provides access and optical networking infrastructure and cloud software solutions in the Americas, Europe, the Middle East, Africa, and Asia. More about DZSMarket Capitalization$101 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$9.00 (+346,053.8% Upside)Volume256,130 sharesAverage Volume83,041 shares9. Zapata Computing NASDAQ:ZPTA$0.0005 0.00 (-50.00%) As of 03/21/2025 11:57 AM EasternZapata Computing Holdings Inc operates as an industrial generative artificial intelligence (AI) software company in the United States. More about Zapata ComputingMarket Capitalization$19 thousandConsensus RatingBuyConsensus Price Target$1.63 (+324,900.0% Upside)Volume2,001 sharesAverage Volume327,915 sharesToday's Range$0.0005▼$0.000510. eFFECTOR Therapeutics NASDAQ:EFTR$0.0006 0.00 (0.00%) As of 03/21/2025eFFECTOR Therapeutics, Inc, a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. More about eFFECTOR TherapeuticsMarket Capitalization$3 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$24.00 (+3,999,900.0% Upside)Average Volume2,225 sharesToday's Range$0.0006▼$0.0006 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/17 - 03/21 FedEx Delivers Another Crushing Blow to Its Stock Price Micron Stock Will Retest All-Time Highs This Year Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge? BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock? Affirm Stock: Should You Buy the Dip After Walmart Setback? AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
